610730login-checkStanford Medicine teams awarded $18 million to improve kidney transplant and gene-editing techniques |
The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.
January 10, 2023 – By Erin Digitale
Physician-scientists at Stanford Medicine have received about $18 million from the California Institute for Regenerative Medicine for two projects to advance cutting-edge treatments for children: a clinical trial to allow kidney transplantation without the need for long-term immunosuppression, and a study of a gene-editing treatment for a rare disease that progressively damages the brain, heart and other organs. Read the full press release from the Stanford Medicine News Center here.
610730login-checkStanford Medicine teams awarded $18 million to improve kidney transplant and gene-editing techniques |